Authors
Loading...
Randomized trial identifies biomarkers and prioritizes drug candidates in ovarian cancer, suggesting a new approach for treatment.
Yadav et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: